The US cancer test market is expanding as growing emphasis on early cancer detection and personalized treatment increases demand for advanced diagnostic solutions. Rising adoption of molecular diagnostics, liquid biopsy, biomarker testing, and genetic screening is enabling more precise identification and monitoring of cancer. Increasing cancer awareness, improvements in diagnostic technologies,...